The neuroprotective effects of GLP-1R agonists and their exact mechanisms have been studied in Alzheimer’s disease, Parkinson’s disease, vascular brain injury, epilepsy, and other neuropathological diseases (14, 17, 18). Here, GLP1R is linked to Alzheimer disease.